American Assets Investment Management’s AbbVie ABBV Stock Holding History

American Assets Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.1M	Hold	60,294	–	–	0.89%	35
2025 Q4	$13.8M	Hold	60,294	–	–	0.95%	27
2025 Q3	$14M	Hold	60,294	–	–	1.03%	24
2025 Q2	$11.2M	Hold	60,294	–	–	0.9%	29
2025 Q1	$12.6M	Hold	60,294	–	–	1.11%	21
2024 Q4	$10.7M	Hold	60,294	–	–	0.87%	28
2024 Q3	$11.9M	Hold	60,294	–	–	1.04%	22
2024 Q2	$10.3M	Hold	60,294	–	–	0.97%	25
2024 Q1	$11M	Hold	60,294	–	–	1.04%	21
2023 Q4	$9.34M	Hold	60,294	–	–	0.96%	26
2023 Q3	$8.99M	Hold	60,294	–	–	1%	26
2023 Q2	$8.12M	Hold	60,294	–	–	0.9%	29
2023 Q1	$9.61M	Hold	60,294	–	–	1.11%	18
2022 Q4	$9.74M	Hold	60,294	–	–	1.13%	17
2022 Q3	$8.09M	Hold	60,294	–	–	1.05%	24
2022 Q2	$9.23M	Hold	60,294	–	–	1.15%	21
2022 Q1	$9.77M	Buy	60,294 +5,000	+9%	+$726K	1.03%	23
2021 Q4	$7.49M	Hold	55,294	–	–	0.81%	37
2021 Q3	$5.96M	Hold	55,294	–	–	0.74%	39
2021 Q2	$6.23M	Hold	55,294	–	–	0.82%	35
2021 Q1	$5.98M	Hold	55,294	–	–	0.83%	34
2020 Q4	$5.92M	Buy	55,294 +12,000	+28%	+$1.15M	0.96%	31
2020 Q3	$3.79M	Hold	43,294	–	–	0.78%	40
2020 Q2	$4.25M	Sell	43,294 -2,706	-6%	-$238K	0.96%	28
2020 Q1	$3.5M	Hold	46,000	–	–	0.75%	41
2019 Q4	$4.07M	Hold	46,000	–	–	0.61%	46
2019 Q3	$3.48M	Hold	46,000	–	–	0.56%	46
2019 Q2	$3.35M	Hold	46,000	–	–	0.53%	51
2019 Q1	$3.68M	Hold	46,000	–	–	0.6%	47
2018 Q4	$4.24M	Hold	46,000	–	–	0.76%	39
2018 Q3	$4.33M	Hold	46,000	–	–	0.71%	40
2018 Q2	$4.25M	Hold	46,000	–	–	0.74%	36
2018 Q1	$4.35M	Hold	46,000	–	–	0.83%	34
2017 Q4	$4.45M	Hold	46,000	–	–	0.85%	31
2017 Q3	$4.09M	Hold	46,000	–	–	0.82%	31
2017 Q2	$3.33M	Hold	46,000	–	–	0.69%	45
2017 Q1	$3M	Hold	46,000	–	–	0.61%	50
2016 Q4	$2.88M	Hold	46,000	–	–	0.61%	55
2016 Q3	$2.9M	Hold	46,000	–	–	0.67%	46
2016 Q2	$2.85M	Hold	46,000	–	–	0.69%	46
2016 Q1	$2.63M	Hold	46,000	–	–	0.71%	47
2015 Q4	$2.73M	Hold	46,000	–	–	0.75%	39
2015 Q3	$2.5M	Buy	46,000 +20,500	+80%	+$1.33M	0.76%	37
2015 Q2	$1.71M	Sell	25,500 -17,220	-40%	-$1.12M	0.51%	55
2015 Q1	$2.5M	Hold	42,720	–	–	0.8%	39
2014 Q4	$2.8M	Hold	42,720	–	–	0.88%	38
2014 Q3	$2.47M	Hold	42,720	–	–	0.88%	38
2014 Q2	$2.41M	Hold	42,720	–	–	0.68%	52
2014 Q1	$2.2M	Buy	42,720 +1,220	+3%	+$61.7K	0.69%	48
2013 Q4	$2.19M	Hold	41,500	–	–	0.82%	39
2013 Q3	$1.86M	Buy	41,500 +3,300	+9%	+$146K	0.65%	57
2013 Q2	$1.58M	Buy	+38,200	New	+$1.67M	0.58%	63

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

American Assets Investment Management's ABBV Position: Q1 2026 in Review

American Assets Investment Management held its AbbVie (ABBV) position steady in Q1 2026 at 60,294 shares worth $13.1M. The position accounts for 0.89% of the portfolio, ranked #35.

American Assets Investment Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $14M in Q3 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

American Assets Investment Management held 60,294 shares of AbbVie worth $13.1M as of Q1 2026.
American Assets Investment Management left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.89% of American Assets Investment Management's portfolio in Q1 2026, its #35 holding.
American Assets Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
American Assets Investment Management's AbbVie position peaked at $14M in Q3 2025.
4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on American Assets Investment Management's 13F filing for Q1 2026, filed 11 May 2026.